Association between the SORL1 rs2070045 polymorphism and late-onset Alzheimer's disease: Interaction with the ApoE genotype in the Chinese Han population

Neuroscience Letters

Volumn 559, Issue , 2014, Pages 94-98

  Xue, Xiaofan ^a   Zhang, Milan ^a   Lin, Yicong ^a   Xu, Erhe ^a   Jia, Jianping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; ApoE; Chinese; Single nucleotide polymorphism; Sortilin related receptor L1

Indexed keywords

APOLIPOPROTEIN E; SORTILIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER'S DISEASE; APOE; CHINESE; SINGLE NUCLEOTIDE POLYMORPHISM; SORTILIN-RELATED RECEPTOR L1;

AGE FACTORS; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE;

EID: 84890807884     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.11.042     Document Type: Article

References (35)

1. Ning M., Yang Y., Zhang Z., Chen Z., Zhao T., Zhang D., Zhou D., Xu J., Liu Z., Wang Y., Liu Y., Zhao X., Li W., Li S., He L. Amyloid-beta-Related Genes SORL1 and ACE are genetically associated with risk for late-onset Alzheimer disease in the Chinese population. Alzheimer Dis. Assoc. Disord. 2010, 24:390-396.
2. Selkoe D.J. Alzheimer's disease: genes proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
3. Li Y., Rowland C., Catanese J., Morris J., Lovestone S., O'Donovan M.C., Goate A., Owen M., Williams J., Grupe A. SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiol. Dis. 2008, 29:293-296.
4. Wang F., Shu C., Jia L., Zuo X., Zhang Y., Zhou A., Qin W., Song H., Wei C., Zhang F., Hong Z., Tang M., Wang D.M., Jia J. Exploration of 16 candidate genes identifies the association of IDE with Alzheimer's disease in Han Chinese. Neurobiol. Aging 2012, 33:1014-1019.
5. Kennedy J.L., Farrer L.A., Andreasen N.C., Mayeux R., St George-Hyslop P. The genetics of adult-onset neuropsychiatric disease: complexities and conundra. Science 2003, 302:822-826.
6. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M. Segregation of a missense mutation in the amyloid precursor protein genewith familial Alzheimer's disease. Nature 1991, 349:704-706.
7. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995, 269:973-977.
8. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
9. van der Vlies A.E., Pijnenburg Y.A., Koene T., Klein M., Kok A., Scheltens P., van der Flier W.M. Cognitive impairment in Alzheimer's disease is modified by ApoE genotype. Dement. Geriatr. Cogn. Disord. 2007, 24:98-103.
10. Almeida O.P., Shimokomaki C.M. Apolipoprotein E4 and Alzheimer's disease in Sao Paulo-Brazil. Arquivos de neuropsiquiatria 1997, 55:1-7.
11. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
12. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
13. Izzo G., Forlenza O.V., Santos Bd., Bertolucci P.H., Ojopi E.B., Gattaz W.F., Kerr D.S., et al. Single-nucleotide polymorphisms of GSK3BGAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the ApoE genotype. Clinics (Sao Paulo) 2013, 68:277-280.
14. Bertram L., Tanzi R.E. Genomewide association studies in Alzheimer's disease. Hum. Mol. Genet. 2009, 18:R137-R145.
15. Meng Y., Lee J.H., Cheng R., St George-Hyslop P., Mayeux R., Farrer L.A. Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport 2007, 18:1761-1764.
16. Andersen O.M., Reiche J., Schmidt V., Gotthardt M., Spoelgen R., Behlke J., von Arnim C.A., Breiderhoff T., Jansen P., Wu X., Bales K.R., Cappai R., Masters C.L., Gliemann J., Mufson E.J., Hyman B.T., Paul S.M., Nykjaer A., Willnow T.E. Neuronal sorting protein related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. USA 2005, 102:13461-13466.
17. Offe K., Dodson S.E., Shoemaker J.T., Fritz J.J., Gearing M., Levey A.I., Lah J.J. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J. Neurosci. 2006, 26:1596-1603.
18. Bettens K., Brouwers N., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Sleegers K. SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum. Mutat. 2008, 29:769-770.
19. Lee J.H., Cheng R., Honig L.S., Vonsattel J.P., Clark L., Mayeux R. Association between genetic variants in SORL1 and autopsy-confirmed Alzheimer disease. Neurology 2008, 70:887-889.
20. Lee L.H., Cheng R., Schupf N., Manly J., Lantigua R., Stern Y., Rogaeva E., Wakutani Y., Farrer L., St George-Hyslop P., Mayeux R. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch. Neurol. 2007, 64:501-506.
21. Lee J.H., Chulikavit M., Pang D., Zigman W.B., Silverman W., Schupf N. Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome. Neurosci. Lett. 2007, 425:105-109.
22. Rogaeva E., Meng Y., Lee J.H., Gu Y., Kawarai T., Zou F., Katayama T., Baldwin C.T., Cheng R., Hasegawa H., Chen F., Shibata N., Lunetta K.L., Pardossi-Piquard R., Bohm C., Wakutani Y., Cupples L.A., Cuenco K.T., Green R.C., Pinessi L., Rainero I., Sorbi S., Bruni A., Duara R., Friedland R.P., Inzelberg R., Hampe W., Bujo H., Song Y.Q., Andersen O.M., Willnow T.E., Graff-Radford N., Petersen R.C., Dickson D., Der S.D., Fraser P.E., Schmitt-Ulms G., Younkin S., Mayeux R., Farrer L.A., St George-Hyslop P. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 2007, 39:168-177.
23. Webster J.A., Myers A.J., Pearson J.V., Craig D.W., Hu-Lince D., Coon K.D., Zismann V.L., Beach T., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Huentelman M.J., Joshipura K., Walker D., Heward C.B., Ravid R., Rogers J., Papassotiropoulos A., Hardy J., Reiman E.M., Stephan D.A. SORL1 as an Alzheimer's disease predisposition gene. Neurodegener. Dis. 2008, 5:60-64.
24. Cousin E., Macé S., Rocher C., Dib C., Muzard G., Hannequin D., Pradier L., Deleuze J.F., Génin E., Brice A., Campion D. No replication of genetic association between candidate polymorphisms and Alzheimer's disease. Neurobiol. Aging 2011, 32:1443-1451.
25. Minster R.L., DeKosky S.T., Kamboh M.I. No association of SORL1 SNPs with Alzheimer's disease. Neurosci. Lett. 2008, 440:190-192.
26. Reitz C., Cheng R., Rogaeva E., Lee J.H., Tokuhiro S., Zou F., Bettens K., Sleegers F., Tan E.K., Kimura R., Shibata N., Arai H., Kamboh M.I., Prince J.A., Maier W., Riemenschneider M., Owen M., Harold D., Hollingworth P., Cellini E., Sorbi S., Nacmias B., Takeda M., Pericak-Vance M.A., Haines J.L., Younkin S., Williams J., van Broeckhoven C., Farrer L.A., St George-Hyslop P.H., Mayeux R. Genetic and environmental risk in Alzheimer disease 1 consortium, meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch. Neurol. 2011, 68:99-106.
27. Tan E.K., Lee J., Chen C.P., Teo Y.Y., Zhao Y., Lee W.L. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese. Neurobiol. Aging 2009, 30:1048-1051.
28. Kimura R., Yamamoto M., Morihara T., Akatsu H., Kudo T., Kamino K., Takeda M. SORL1 is genetically associated with Alzheimer disease in a Japanese population. Neurosci. Lett. 2009, 461:177-180.
29. Shibata N., Ohnuma T., Baba H., Higashi S., Nishioka K., Arai H. Genetic association between SORL1 polymorphisms and Alzheimer's disease in a Japanese population. Dement. Geriatr. Cogn. Disord. 2008, 26:161-164.
30. Kölsch H., Jessen F., Wiltfang J., Lewczuk P., Dichgans M., Teipel S.J., Kornhuber J., Frölich L., Heuser I., Peters O., Wiese B., Kaduszkiewicz H., van den Bussche H., Hüll M., Kurz A., Rüther E., Henn F.A., Maier W. Association of SORL1 gene variants with Alzheimer's disease 2009, 1264:1-6.
31. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
32. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
33. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 1990, 31:545-548.
34. Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNP. Stats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
35. Kölsch H., Jessen F., Wiltfang J., Lewczuk P., Dichgans M., Kornhuber J., Frölich L., Heuser I., Peters O., Schulz J.B., Schwab S.G., Maier W. Influence of SORL1 gene variants: association with CSF amyloid-β products in probable Alzheimer's disease. Neurosci. Lett. 2008, 440:68-71.